Lori Murray
Investor Relations Contact presso RUBIUS THERAPEUTICS
Profilo
Lori Murray is currently the Chief Corporate Affairs Officer at Rubius Therapeutics, Inc. She previously worked at Onyx Pharmaceuticals, Inc. as the Head-Media Relations from 2009 to 2015.
Ms. Murray completed her undergraduate degree at the University of California, Davis and holds an MBA from the University of San Francisco.
Posizioni attive di Lori Murray
| Società | Posizione | Inizio |
|---|---|---|
| RUBIUS THERAPEUTICS | Investor Relations Contact | 01/06/2018 |
Precedenti posizioni note di Lori Murray
| Società | Posizione | Fine |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | 01/12/2015 |
Formazione di Lori Murray
| University of California, Davis | Undergraduate Degree |
| University of San Francisco | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Borsa valori
- Insiders
- Lori Murray
